Victor A. Medina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victor A. Medina has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Bautista
Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia
1 shared publication Adriana María García Muñoz
1 shared publicationAlba Mery Gómez Castañeda
1 shared publication- Alejandra Arévalo
Global Health Research Unit for the Genomic Surveillance of Antimicrobial Resistance-Colombia, CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Mosquera, Colombia
1 shared publication Ana Maria Montoya
1 shared publicationAna Yadira Santana
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (5) , 001725
Genetic structure of penicillin non-susceptible invasive Streptococcus pneumoniae in Colombia
Background. Infections caused by Streptococcus pneumoniae are a public health problem worldwide, and penicillin-non-susceptible isolates are a priority for the World Health Organization, which requires further research and development of new antibiotics and vaccines. Aim. To describe the global pneumococcal sequence clusters (GPSCs) among penicillin non-susceptible S. pneumoniae isolates obtained from patients with invasive pneumococcal disease in Colombia after the introduction of PCV10 (Synflorix, GlaxoSmithKline) to generate data on the genetic structure of pneumococcal populations with different antimicrobial susceptibilities. Methods. A subset of 313 pneumococcal isolates with values of Minimum Inhibitory Concentration to penicillin of ≥0.125 µg ml −1 , collected through the National Reference Laboratory at the National Health Institute of Colombia, were characterized by whole-genome sequencing to determine the GPSCs, serotypes, sequence types, antimicrobial resistance determinants and pilus islets. Results. Most of the isolates (80%, n =251) were clustered in seven GPSCs: multidrug-resistant GPSC1 (40.6%, n =127) conformed principally to serotype 19A isolates and ST320, GPSC5 (10.5%, n =33) associated with ST338 and isolates of serogroups 23 and 6, GPSC13 (7.3%, n =23) which clustered 68% of 6A isolates, GPSC10 (7.0%, n =22) with 19A and 24F isolates, GPSC6 (5.4%, n =17) related to ST156, GPSC9 (4.8%, n =15) conformed to isolates 15A, 19 F/A and 6A and GPSC47 (4.5%, n =14) with 6C isolates. Only three isolates with PCV10 serotypes were recovered from children younger than 5 years old. Conclusion. The results revealed changes in the population structure expected after PCV10 introduction, with GPSC1 being the most important clone due to its association with multidrug resistance. Genome sequencing of clinical multidrug-resistant isolates contributes to elucidating the antibiotic resistance mechanism and understanding the global pneumococcal population structure.
- 19 May 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (5) , 001725
Open AccessGenetic structure of penicillin non-susceptible invasive Streptococcus pneumoniae in Colombia
Background. Infections caused by Streptococcus pneumoniae are a public health problem worldwide, and penicillin-non-susceptible isolates are a priority for the World Health Organization, which requires further research and development of new antibiotics and vaccines. Aim. To describe the global pneumococcal sequence clusters (GPSCs) among penicillin non-susceptible S. pneumoniae isolates obtained from patients with invasive pneumococcal disease in Colombia after the introduction of PCV10 (Synflorix, GlaxoSmithKline) to generate data on the genetic structure of pneumococcal populations with different antimicrobial susceptibilities. Methods. A subset of 313 pneumococcal isolates with values of Minimum Inhibitory Concentration to penicillin of ≥0.125 µg ml −1 , collected through the National Reference Laboratory at the National Health Institute of Colombia, were characterized by whole-genome sequencing to determine the GPSCs, serotypes, sequence types, antimicrobial resistance determinants and pilus islets. Results. Most of the isolates (80%, n =251) were clustered in seven GPSCs: multidrug-resistant GPSC1 (40.6%, n =127) conformed principally to serotype 19A isolates and ST320, GPSC5 (10.5%, n =33) associated with ST338 and isolates of serogroups 23 and 6, GPSC13 (7.3%, n =23) which clustered 68% of 6A isolates, GPSC10 (7.0%, n =22) with 19A and 24F isolates, GPSC6 (5.4%, n =17) related to ST156, GPSC9 (4.8%, n =15) conformed to isolates 15A, 19 F/A and 6A and GPSC47 (4.5%, n =14) with 6C isolates. Only three isolates with PCV10 serotypes were recovered from children younger than 5 years old. Conclusion. The results revealed changes in the population structure expected after PCV10 introduction, with GPSC1 being the most important clone due to its association with multidrug resistance. Genome sequencing of clinical multidrug-resistant isolates contributes to elucidating the antibiotic resistance mechanism and understanding the global pneumococcal population structure.
- Open Access
- 21 July 2025
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 3 (1) , 1-11
Epidemiological Genomics of Klebsiella pneumoniae isolates from hospitals across Colombia
Klebsiella pneumoniae is one of the most important nosocomial pathogens worldwide. In Colombia, K. pneumoniae has been identified as the second most frequent microbial etiologic agent of healthcare-associated infections. We conducted a prospective local study of 335 K. pneumoniae isolates in 26 nationwide hospitals from 2020 to 2021. We found that the spread of carbapenem resistance was mediated by successful clones belonging to sequence types (ST) such as ST11, ST1082, and ST307, related to intra-hospital infections. We observed that blaKPC remains the primary resistance mechanism to carbapenems and that, unlike other countries, ST11 strains commonly carry blaKPC-3. We identified the recent introduction and circulation of new sequence types with different resistance mechanisms and hypervirulence. Besides, we detected possible transmission events closely linked to carbapenemase-carrying strains, mainly in intensive care units. This study helps us understand how K. pneumoniae disseminates in Colombian hospitals and where to direct effective intervention measures.
- 21 July 2025
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 3 (1) , 1-11
Open AccessEpidemiological Genomics of Klebsiella pneumoniae isolates from hospitals across Colombia
Klebsiella pneumoniae is one of the most important nosocomial pathogens worldwide. In Colombia, K. pneumoniae has been identified as the second most frequent microbial etiologic agent of healthcare-associated infections. We conducted a prospective local study of 335 K. pneumoniae isolates in 26 nationwide hospitals from 2020 to 2021. We found that the spread of carbapenem resistance was mediated by successful clones belonging to sequence types (ST) such as ST11, ST1082, and ST307, related to intra-hospital infections. We observed that blaKPC remains the primary resistance mechanism to carbapenems and that, unlike other countries, ST11 strains commonly carry blaKPC-3. We identified the recent introduction and circulation of new sequence types with different resistance mechanisms and hypervirulence. Besides, we detected possible transmission events closely linked to carbapenemase-carrying strains, mainly in intensive care units. This study helps us understand how K. pneumoniae disseminates in Colombian hospitals and where to direct effective intervention measures.